Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2025-12-24 @ 4:43 PM
NCT ID: NCT01447966
Eligibility Criteria: Inclusion Criteria: * Meets DSM-IV-TR for a primary diagnosis of OCD * Minimum score of 8 on the CYBOCS compulsion scale * Peabody Picture Vocabulary IV score of 80 * Able to attend biweekly appointments with a parent/guardian * English Speaking Exclusion Criteria: * Current clinically significant suicidality * engaged in suicidal behaviors within 6 months * Peabody Picture Vocabulary IV score of 80 * Any change in established psychotropic medication (e.g., antidepressants, anxiolytics) within 4 weeks before study enrollment, any change in antipsychotics within 3 weeks prior to the screening assessment, any change in Prozac or Straterra within 6 weeks of study enrollment, and any change in alpha-2 agonists or stimulants within 1 week of study enrollment. * Lifetime DSM-IV bipolar, schizophrenia or schizoaffective disorders; or Substance abuse in past 6 months. * Absence of language * Formal diagnosis of mental retardation or an autism spectrum disorder * Unwillingness of parents to make the commitment to accompany their child for multiple study visits, unwillingness to take part in randomization, inability to attend sessions twice weekly as therapist availability allows, inability to attend assessment visits. * Presence of a significant and/or unstable medical illness which might lead to hospitalization during the study.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 3 Years
Maximum Age: 8 Years
Study: NCT01447966
Study Brief:
Protocol Section: NCT01447966